Saturday - August 1, 2026
Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients with Advanced Non-Small Cell Lung Cancer Live Longer
January 20, 2026
BOSTON, Massachusetts, Jan. 20 [Category: BizHospital] -- The Dana-Farber Cancer Institute issued the following news release:

* * *

Dana-Farber Study Finds Dual Immunotherapy May Help Certain Patients with Advanced Non-Small Cell Lung Cancer Live Longer

*

Research Summary

Study Title : Dual Versus Single Checkpoint Inhibition in Advanced Non-Small Cell Lung Cancer: A Pooled Patient-Level Analysis of Six Randomized Trials
. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products

Click here for more information about our products